Abstract:Background MYB-related protein B (B-MYB/MYBL2), a member of the myeloblastosis family of transcription factors, has been reported for its role in the genesis and progression of tumors. Forkhead box M1 (FoxM1), another transcriptional factor, is considered to be an independent predictor of poor survival in many solid cancers. The aim of the present study was to investigate the clinical significance of the correlation between MYBL2 and FoxM1 in glioma and the possible mechanism of FoxM1and MYBL2 expression. Methods MYBL2 and FoxM1expression in cancerous tissues and cell lines were determined by reverse transcription-PCR (RT-PCR), Western blotting and immunostaining. The co-expression of MYBL2 and FoxM1 was analyzed in low-grade glioma (LGG) and glioblastoma (HGG) cohorts of TCGA using cBioportal and UCSC Xena. And, the role of MYBL2 and FoxM1 in glioma cell progression and the underlying mechanisms were studied by using small interfering RNA (si-RNA) and pcDNA3.1 + HAvectors. Furthermore, the effects of MYBL2 and FoxM1 in cell proliferation, cell cycle progression, apoptosis, migration, invasion, and adhesion were determined by cell proliferation assays, flow cytometry analysis, transwell migration and cell adhesion assay. Results MYBL2 and FoxM1 expression are significantly associated with clinical stages and overall survival of glioma patients. In cohorts of TCGA, patients with high MYBL2 but without radio-chemotherapy had the highest hazard ratio (adjusted HR = 5.29, 95% CI = 1.475–18.969, P < 0.05). Meanwhile, MYBL2 closely related to the FoxM1 expression in 79 glioma tissues ( r = 0.742, p < 0.05) and LGG ( r = 0.83) and HGG ( r = 0.74) cohorts of TCGA. Down regulation of FoxM1 and MYBL2 by siRNAs induced the cell cycle arrest, apoptosis and EMT of glioma cells. Furthermore, inactivations of Akt/FoxM1 signaling by Akt inhibitor and siRNA-FoxM1 reduce the expression of MYBL2 in glioma cells. Conclusions MYBL2 is a key downstream factor of Akt/FoxM1 signaling to promote progression of human glioma, and could be a new candidate gene for molecular targeting therapy and biomarker for radiotherapy of glioma. Trial registration CTXY-1300041-3-2 . ChiCTR-COC-15006186 . Registered date: 13 September 2013.

Overexpression of MYBL2 Promotes Proliferation and Migration of Non-Small-cell Lung Cancer Via Upregulating NCAPH

MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3

Prognostic Implications of MYBL2 in Resected Chinese Gastric Adenocarcinoma Patients

Downstream Regulatory Network of MYBL2 Mediating Its Oncogenic Role in Melanoma

SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression

Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway.

Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and MYBL2 on Ras/ErbB signaling

MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.

Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma

Mybl2 is A Potential Prognostic Marker That Promotes Cell Proliferation in Gallbladder Cancer

Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration

MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma

COPB2 Promotes Cell Proliferation and Tumorigenesis Through Up-Regulating YAP1 Expression in Lung Adenocarcinoma Cells.

Identification ofLBX2as a novel causal gene of lung adenocarcinoma

MYC/MAX-Activated LINC00958 Promotes Lung Adenocarcinoma by Oncogenic Transcriptional Reprogramming Through HOXA1 Activation

MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis

Genome-wide binding analysis unveils critical implication of B-Myb-mediated transactivation in cancers

Abstract 5426: SMC2 Orchestrates Non-Small Cell Lung Cancer Proliferation, Invasion, and Metastasis by Modulating the ERK/AKT/NF-κB Pathways

Extracellular vesicles containing circMYBL1 induce CD44 in adenoid cystic carcinoma cells and pulmonary endothelial cells to promote lung metastasis

The Long Noncoding RNA LINC00665 Facilitates c-Myc Transcriptional Activity via the miR-195-5p MYCBP Axis to Promote Progression of Lung Adenocarcinoma

NCAPH is Negatively Associated with Mcl‑1 in Non‑small Cell Lung Cancer